WebCunningham SC, Spinoulas A, Carpenter KH et al (2009) AAV2/8-mediated correction of OTC deficiency is robust in adult but not neonatal spf ash mice. Mol Ther 17(8):1340–1346 Cunningham SC, Kok CY, Dane AP et al (2011) Induction and prevention of severe hyperammonemia in the spf ash mouse model of ornithine transcarbamylase deficiency … WebApr 1, 1999 · Background. The mouse strain sparse fur with abnormal skin and hair (spf ash) is a model for the human ornithine transcarbamylase (OTC) deficiency, an X-linked …
Corticosteroid suppresses urea-cycle-related gene expressions in ...
WebMay 1, 2011 · A single tail vein injection of 3x10e11 GC of vector in Spf ash mice restored the OTC enzyme activity in the livers of treated mice to a level similar to wild-type. In the current study, we replaced the murine OTC gene with a codon-optimized human OTC gene. Robust OTC gene expression and correction of OTCD were achieved in Spf ash mice. WebDec 21, 2016 · OTC intron 4 variations mediate pathogenic splicing patterns caused by the c.386G>A mutation in humans and spf(ash) mice, and govern susceptibility to RNA-based therapies. Sacchetto C, et al. Mol Med, 2024 Dec 14. PMID 34906067, Free PMC Article; Common polymorphic OTC variants can act as genetic modifiers of enzymatic activity. … data remediation significato
Functional characterization of the spf/ash splicing variation in OTC ...
WebApr 7, 2024 · Two mouse models for OTCD are currently being used: the sparse fur (spf) mouse, which carries a missense mutation that results in partial (10%) activity of the OTC … WebThe spf ash mouse model carries a variant (c.386G>A, p.Arg129His) that is also found in patients. Male spf ash mice have a mild biochemical phenotype with low OTC activity (5% … WebShimada, T., Noda, T., Tashiro, M., Murakami, T., Takiguchi, M., Mori, M., … Saheki, T. (1991). Correction of ornithine transcarbamylase (OTC) deficiency in spf-ash ... data remediation 1